|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$1,197.00 |
|
|
 |
ALBUMIN HUMAN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS CITRIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BENZYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|